These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31056995)

  • 1. Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.
    Shi Z; Qin T; Xu Z; Li B; Huang H; Zhang H; Fang L; Pan L; Hu N; Qu S; Huang G; Gale RP; Xiao Z
    Leuk Lymphoma; 2019 Nov; 60(11):2835-2837. PubMed ID: 31056995
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression.
    DiNardo CD; Jabbour E; Ravandi F; Takahashi K; Daver N; Routbort M; Patel KP; Brandt M; Pierce S; Kantarjian H; Garcia-Manero G
    Leukemia; 2016 Apr; 30(4):980-4. PubMed ID: 26228814
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic analysis and clinical picture of severe congenital neutropenia in Israel.
    Lebel A; Yacobovich J; Krasnov T; Koren A; Levin C; Kaplinsky C; Ravel-Vilk S; Laor R; Attias D; Ben Barak A; Shtager D; Stein J; Kuperman A; Miskin H; Dgany O; Giri N; Alter BP; Tamary H
    Pediatr Blood Cancer; 2015 Jan; 62(1):103-8. PubMed ID: 25284454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male sex and the pattern of recurrent myeloid mutations are strong independent predictors of blood transfusion intensity in patients with myelodysplastic syndromes.
    Rydén J; Edgren G; Karimi M; Walldin G; Tobiasson M; Wikman A; Hellström-Lindberg E; Höglund P
    Leukemia; 2019 Feb; 33(2):522-527. PubMed ID: 30267009
    [No Abstract]   [Full Text] [Related]  

  • 6. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome.
    Cordoba I; Gonzalez-Porras JR; Such E; Nomdedeu B; Luño E; de Paz R; Carbonell F; Vallespi T; Ardanaz M; Ramos F; Marco V; Bonanad S; Sanchez-Barba M; Costa D; Bernal T; Sanz GF; Cañizo MC
    Leuk Res; 2012 Mar; 36(3):287-92. PubMed ID: 22133642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
    Chen Z; Wang SA; Goswami M; Tang G; Routbort MJ; Patel KP; Luthra R; Medeiros LJ; Ok CY
    Leuk Res; 2019 Nov; 86():106227. PubMed ID: 31557598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents.
    Takahashi K; Patel K; Bueso-Ramos C; Zhang J; Gumbs C; Jabbour E; Kadia T; Andreff M; Konopleva M; DiNardo C; Daver N; Cortes J; Estrov Z; Futreal A; Kantarjian H; Garcia-Manero G
    Oncotarget; 2016 Mar; 7(12):14172-87. PubMed ID: 26871476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients.
    Buradkar A; Bezerra E; Coltro G; Lasho TL; Finke CM; Gangat N; Carr RM; Binder M; Mangaonkar AA; Ketterling R; Khan S; Rodriguez V; Tefferi A; Patnaik MM
    Leukemia; 2021 Feb; 35(2):644-649. PubMed ID: 32513965
    [No Abstract]   [Full Text] [Related]  

  • 11. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
    Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
    Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case 37: Neutropenia and macrocytosis in a middle-aged man.
    Mangles SE; Abdalla SH; Gabriel CM; Bain BJ
    Leuk Lymphoma; 2007 Sep; 48(9):1846-8. PubMed ID: 17786722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome.
    Kita-Sasai Y; Horiike S; Misawa S; Kaneko H; Kobayashi M; Nakao M; Nakagawa H; Fujii H; Taniwaki M
    Br J Haematol; 2001 Nov; 115(2):309-12. PubMed ID: 11703325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms.
    Negri G; Crescenzi B; Colombo EA; Fontana L; Barba G; Arcioni F; Gervasini C; Mecucci C; Larizza L
    Br J Haematol; 2015 Nov; 171(4):557-65. PubMed ID: 26306619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
    Tang Y; Miao M; Han S; Qi J; Wang H; Ruan C; Wu D; Han Y
    Crit Rev Oncol Hematol; 2019 Jan; 133():74-83. PubMed ID: 30661660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome.
    Rujirachaivej P; Siriboonpiputtana T; Rerkamnuaychoke B; Magmuang S; Chareonsirisuthigul T; Boonsakan P; Petvises S; Sirirat T; Niparuck P; Chuncharunee S
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1825-1831. PubMed ID: 30049194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myelodysplastic syndromes].
    Thol F; Heuser M; Ganser A
    Internist (Berl); 2015 Apr; 56(4):364-73. PubMed ID: 25700647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
    Zhang MY; Keel SB; Walsh T; Lee MK; Gulsuner S; Watts AC; Pritchard CC; Salipante SJ; Jeng MR; Hofmann I; Williams DA; Fleming MD; Abkowitz JL; King MC; Shimamura A
    Haematologica; 2015 Jan; 100(1):42-8. PubMed ID: 25239263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes (MDS) in regular care in Germany - the oldest patients come to the fore.
    Steinmetz HT; Germing U; Sauer A; Lathan B; Liersch R; Tesch H; Heßling J; Moorahrend E; Uhlig J; Reiser M; Wahdat R; Gattermann N; Totzke U; Schmitz S
    Leuk Lymphoma; 2018 May; 59(5):1244-1247. PubMed ID: 28914552
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutropenia at baseline could indicate poor prognosis in low/intermediate risk myelodysplastic syndrome patients.
    Breccia M; Loglisci G; Salaroli A; Finsinger P; Serrao A; Petrucci L; Alimena G
    Leuk Res; 2012 May; 36(5):546-7. PubMed ID: 22309889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.